February 9, Minsk /BELTA/. Tuberculosis incidence decreased by 43.1% from 2015 to 2019. This data is provided in the text of the state program "People's Health and Demographic Security" for 2021-2025, reports BELTA.
February 9, Minsk /BELTA/. Tuberculosis incidence decreased by 43.1% from 2015 to 2019. This data is provided in the text of the state program "People's Health and Demographic Security" for 2021-2025, reports BELTA.
According to the state program, this indicator (including relapses) should decrease to 19.3 per 100,000 population over the next five years.
Thanks to the measures taken for the prevention and control of tuberculosis, the mortality rate from tuberculosis decreased by 45% from 2015 to 2019 (from 4 to 2.2 per 100,000 population). It is expected that by 2025, a decrease to 2.11 per 100,000 population will occur. At the same time, over the specified period, the proportion of patients with multidrug-resistant tuberculosis increased by 35.3% (from 54.7% to 74%).
It is also envisaged that the proportion of patients with multidrug-resistant forms of tuberculosis who have successfully completed a full course of treatment (9-24 months) will increase to 79% of the total number of such patients over five years.
The state program defines key areas of activity that will help solve existing problems. It is planned to increase the accessibility of prevention, diagnosis and treatment of tuberculosis for vulnerable population groups (persons suffering from chronic alcoholism, drug users, patients with HIV infection). Existing regulatory legal acts on the provision of specialized medical care will be revised, and new ones will be developed.
The procurement of medicines for the treatment of patients with drug-susceptible and rifampicin-resistant tuberculosis is expected not only from the republican and local budgets but also through attracting funds from other sources. For patients with rifampicin-resistant tuberculosis, effective modified shortened treatment regimens will be applied within the framework of an international multi-country operational study in accordance with WHO recommendations.